Feb 28 (Reuters) - Somnomed Ltd SOM.AX:
H1 REVENUE AUD 53.7 MILLION
H1 EBITDA AUD 5.8 MILLION
UPGRADED FY25 GUIDANCE CAPEX OF BETWEEN A$3 MILLION TO A$4 MILLION
SEES FY25 EBITDA OF BETWEEN A$7 MILLION TO A$9 MILLION
FY25 GUIDANCE REVENUE OF APPROXIMATELY A$105 MILLION
Further company coverage: SOM.AX
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.